RAHMAT GUL: Open Payments
NPI 1699443911 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 18 payments from 9 companies in 2025. Trend: 2023 $244 · 2024 $174 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $87 |
| Novo Nordisk Inc | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Amgen Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Viatris Specialty LLC | 1 | $19 |
| ABBVIE INC. | 1 | $15 |
Products named: MOUNJARO, KISUNLA, XIFAXAN, Kerendia, OTEZLA, AIRSUPRA, SPRAVATO, YUPELRI.
Industry payments across NY — which companies pay providers there.
